Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts
Completed
bioRASI, LLC
Phase 3
2018-04-20
A clinical endpoint bioequivalence (BE) study for a Podofilox Gel 0.5% formulation for the
treatment of external anogenital warts in comparison to Condylox® Gel 0.5% that follows the
study design and recommendations according to Office of Generic Drugs (OGD) of U.S. Food and
Drug Administration (FDA) Draft Guidance for Podofilox recommendations
Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts
Completed
Hyloris Developments SA
Phase 3
2018-04-20
A clinical endpoint bioequivalence (BE) study for a Podofilox Gel 0.5% formulation for the
treatment of external anogenital warts in comparison to Condylox® Gel 0.5% that follows the
study design and recommendations according to Office of Generic Drugs (OGD) of U.S. Food and
Drug Administration (FDA) Draft Guidance for Podofilox recommendations
Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts
Completed
Dermax SA
Phase 3
2018-04-20
A clinical endpoint bioequivalence (BE) study for a Podofilox Gel 0.5% formulation for the
treatment of external anogenital warts in comparison to Condylox® Gel 0.5% that follows the
study design and recommendations according to Office of Generic Drugs (OGD) of U.S. Food and
Drug Administration (FDA) Draft Guidance for Podofilox recommendations
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
